158 related articles for article (PubMed ID: 20815904)
1. Coordination of glioblastoma cell motility by PKCι.
Baldwin RM; Barrett GM; Parolin DA; Gillies JK; Paget JA; Lavictoire SJ; Gray DA; Lorimer IA
Mol Cancer; 2010 Sep; 9():233. PubMed ID: 20815904
[TBL] [Abstract][Full Text] [Related]
2. NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop.
Shen J; Xu L; Owonikoko TK; Sun SY; Khuri FR; Curran WJ; Deng X
Cancer Lett; 2012 May; 318(1):106-13. PubMed ID: 22178655
[TBL] [Abstract][Full Text] [Related]
3. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
[TBL] [Abstract][Full Text] [Related]
4. Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling.
Baldwin RM; Garratt-Lalonde M; Parolin DA; Krzyzanowski PM; Andrade MA; Lorimer IA
Oncogene; 2006 May; 25(20):2909-19. PubMed ID: 16331246
[TBL] [Abstract][Full Text] [Related]
5. Atypical PKCι as target for glioblastoma therapy.
Lorimer IA
Curr Cancer Drug Targets; 2015; 15(2):136-44. PubMed ID: 25643257
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C
Kenchappa RS; Liu Y; Argenziano MG; Banu MA; Mladek AC; West R; Luu A; Quiñones-Hinojosa A; Hambardzumyan D; Justilien V; Leitges M; Sarkaria JN; Sims PA; Canoll P; Murray NR; Fields AP; Rosenfeld SS
Cell Rep; 2021 Nov; 37(8):110054. PubMed ID: 34818553
[TBL] [Abstract][Full Text] [Related]
7. Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells.
Wald FA; Oriolo AS; Mashukova A; Fregien NL; Langshaw AH; Salas PJ
J Cell Sci; 2008 Mar; 121(Pt 5):644-54. PubMed ID: 18270268
[TBL] [Abstract][Full Text] [Related]
8. PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.
Gont A; Hanson JE; Lavictoire SJ; Parolin DA; Daneshmand M; Restall IJ; Soucie M; Nicholas G; Woulfe J; Kassam A; Da Silva VF; Lorimer IA
Oncotarget; 2013 Aug; 4(8):1266-79. PubMed ID: 23907540
[TBL] [Abstract][Full Text] [Related]
9. PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma.
Ni S; Chen L; Li M; Zhao W; Shan X; Wu M; Cheng J; Liang L; Wang Y; Jiang W; Zhang J; Ni R
Tumour Biol; 2016 Oct; 37(10):13799-13809. PubMed ID: 27481515
[TBL] [Abstract][Full Text] [Related]
10. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
[TBL] [Abstract][Full Text] [Related]
11. PKCι depletion initiates mitotic slippage-induced senescence in glioblastoma.
Restall IJ; Parolin DA; Daneshmand M; Hanson JE; Simard MA; Fitzpatrick ME; Kumar R; Lavictoire SJ; Lorimer IA
Cell Cycle; 2015; 14(18):2938-48. PubMed ID: 26208522
[TBL] [Abstract][Full Text] [Related]
12. Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase.
Jin Z; Xin M; Deng X
J Biol Chem; 2005 Apr; 280(16):16045-52. PubMed ID: 15705582
[TBL] [Abstract][Full Text] [Related]
13. Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids.
Linch M; Sanz-Garcia M; Rosse C; Riou P; Peel N; Madsen CD; Sahai E; Downward J; Khwaja A; Dillon C; Roffey J; Cameron AJ; Parker PJ
Carcinogenesis; 2014 Feb; 35(2):396-406. PubMed ID: 24072773
[TBL] [Abstract][Full Text] [Related]
14. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma.
Kim KH; Chung C; Kim JM; Lee D; Cho SY; Lee TH; Cho HJ; Yeo MK
BMC Cancer; 2019 Aug; 19(1):804. PubMed ID: 31412817
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor promotes the translocation of protein kinase Ciota in neutrophilic differentiation cells.
Kanayasu-Toyoda T; Suzuki T; Oshizawa T; Uchida E; Hayakawa T; Yamaguchi T
J Cell Physiol; 2007 Apr; 211(1):189-96. PubMed ID: 17133348
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma.
Erdogan E; Klee EW; Thompson EA; Fields AP
Clin Cancer Res; 2009 Mar; 15(5):1527-33. PubMed ID: 19223491
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glioblastoma cell invasion by PKC iota and RhoB.
Baldwin RM; Parolin DA; Lorimer IA
Oncogene; 2008 Jun; 27(25):3587-95. PubMed ID: 18212741
[TBL] [Abstract][Full Text] [Related]
19. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
Fields AP; Frederick LA; Regala RP
Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.
Scotti ML; Bamlet WR; Smyrk TC; Fields AP; Murray NR
Cancer Res; 2010 Mar; 70(5):2064-74. PubMed ID: 20179210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]